Quoin Pharmaceuticals, Ltd. (QNRX)

$4.24

-0.05 (-1.17%)
Rating:
Recommendation:
-
Symbol QNRX
Price $4.24
Beta 0.000
Volume Avg. 0.16M
Market Cap 4.186M
Shares () -
52 Week Range 4.2-39.36
1y Target Est -
DCF Unlevered QNRX DCF ->
DCF Levered QNRX LDCF ->
ROE -111.70% Strong Sell
ROA -61.10% Strong Sell
Operating Margin -
Debt / Equity -
P/E 0.01 Neutral
P/B 0.04 Neutral
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest QNRX news


Dr. Michael Myers Ph.D.
Healthcare
Biotechnology
NASDAQ Capital Market

Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.